ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,575Medicare Part D Prescriptions Filled, Including Refills

Rank: 207 out of 890

$639K Total Retail Price of All Prescriptions

Rank: 174 out of 890

408 Patients Receiving at Least One Drug in Part D
53%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 408 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

20% of this provider’s 408 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 5,971 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 376 142 S3 1 3
METFORMIN HCL 314 210 2 6
AMLODIPINE BESYLATE 313 252 3 1
OMEPRAZOLE 224 149 4 8
SIMVASTATIN 222 135 5 5
FUROSEMIDE 217 134 6 7
HYDROCHLOROTHIAZIDE 207 121 7 9
NEXIUM 188 74 8 14
LEVOTHYROXINE SODIUM 161 96 9 2
ZOLPIDEM TARTRATE 150 82 10 19
GABAPENTIN 147 84 11 12
TRAMADOL HCL 126 92 12 16
DIOVAN HCT 122 38 13 48
DIOVAN 115 83 14 33
LISINOPRIL 110 90 15 4
CLONIDINE HCL 109 31 16 35
METOPROLOL TARTRATE 108 85 17 15
BUMETANIDE 105 77 18 134
AZITHROMYCIN 104 53 19 37
AMITRIPTYLINE HCL 98 54 R 20 43
METOPROLOL SUCCINATE 96 78 21 17
POTASSIUM CHLORIDE 93 77 22 11
GLIMEPIRIDE 93 76 22 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 47 24 21
ATORVASTATIN CALCIUM 87 64 25 13
PANTOPRAZOLE SODIUM 81 60 26 34
FENOFIBRATE 80 36 27 74
PLAVIX 79 63 28 42
KLOR-CON 10 79 55 28 189
AMLODIPINE BESYLATE-BENAZEPRIL 77 62 30 41
PRAVASTATIN SODIUM 72 51 31 10
CLOPIDOGREL 69 51 32 28
FLUOXETINE HCL 68 0 33 63
SERTRALINE HCL 66 37 34 26
KLOR-CON M20 66 48 34 72
BENAZEPRIL HCL 63 47 36 44
PREDNISONE 63 19 36 47
PROAIR HFA 62 15 38 55
ADVAIR DISKUS 61 25 39 52
CARISOPRODOL 60 20 R 40 69
TRAZODONE HCL 60 0 40 40
CYCLOBENZAPRINE HCL 60 25 R 40 64
DIGOXIN 59 57 43 65
CRESTOR 59 44 43 25
DILTIAZEM ER 59 51 43 129
ALLOPURINOL 58 38 46 31
SINGULAIR 56 18 47 79
HYDROXYZINE HCL 56 17 R 47 200
CIPROFLOXACIN HCL 55 37 49 58
ATENOLOL 54 40 50 23
POLYETHYLENE GLYCOL 3350 54 15 50 67
DONEPEZIL HCL 53 35 52 30
OLANZAPINE 52 16 53 145
IBUPROFEN 52 29 53 101
PAROXETINE HCL 52 35 53 68
FLUTICASONE PROPIONATE 51 19 56 39
JANUMET 50 42 57 194
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.